Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Walgreens Boots Alliance Inc. (NASDAQ: WBA) published its earnings report for the fiscal third quarter on Thursday that topped analysts' estimates for earnings and revenue. Shares of the company still slid about 7% on Thursday morning.

Analyst: this is why Walgreens stock slid on Thursday despite market-beating results

As people get out again, the drugstore chain said they are refreshing their makeup bags and ordering passport photos.

Walgreens said it's seeing a comeback in discretionary spending. Here are three areas driving growth

Walgreens Boots (WBA) revenues improve 12.1% year-over-year in the third quarter on robust growth in the International and United States segments.

Walgreens Boots (WBA) Q3 Earnings Top Estimates, 2021 View Up

For Walgreens, the rollout of its sweeping COVID-19 vaccine program this year was a demonstration of the company's ability to move quickly and at scale as it accelerates the transformation and restructuring of its pharmacy and retail businesses. Walgreens, the second-largest drug store chain in the U.S. behind CVS, has been focused on reinventing its […]

Walgreens Sees Increased Sales As Personalization Effort Continues

Walgreens administered 25M COVID-19 vaccines and tells investors the pace will slow in the coming weeks and months.

Walgreens administered 25M COVID-19 vaccines, sees pace slowing

Walgreens Boots Alliance Inc (NASDAQ: WBA) reported Q3 earnings of $1.38, beating the consensus estimate of $1.17. Revenue increased 12.1% Y/Y to $34.0 billion, slightly ahead of the consensus of $33.76 billion.

Walgreens Boots Alliance Q3 Earnings Beat Expectations As Vaccinations Boost Prescriptions Business

Despite pointing up in premarket trading, near the bottom of the Dow this morning sits Walgreens Boots Alliance Inc (NASDAQ: WBA), down 7.1% to trade at $48.71 at last check.

Walgreens Stock Pivots Lower Despite Top-Line Beat

Walgreens has administered more than 25 million vaccines against Covid-19, boosting quarterly profits and sales.

Covid Vaccines Boost Walgreens Profits As New CEO Takes Charge

Walgreens Boots Alliance raised its outlook for the year and unveiled its turnaround plans on Thursday, after a stronger than expected fiscal third-quarter.

Walgreens swings to a profit, raises forecast as it looks to accelerate growth under new CEO

Shares of Walgreens Boots Alliance (NASDAQ:WBA) rose 1.5% in pre-market trading after the company reported Q3 results. Quarterly Results Earnings per share were up 66.27% year over year to $1.38, which beat the estimate of $1.17.

Recap: Walgreens Boots Alliance Q3 Earnings

Walgreens Boots Alliance Inc. shares rose 2.8% in Thursday premarket trading after the pharmacy retailer swung to a fiscal third-quarter profit. Net income totaled $1.197 billion, or $1.38 per share, after a loss of $1.708 billion, or $1.95 per share, last year.

Walgreens swings to a profit

Walgreens Boots Alliance Inc on Thursday raised its 2021 adjusted profit growth forecast, buoyed by strength in drug sales and COVID-19 vaccine administrations.

Walgreens raises FY profit growth forecast on strength in drug sales

DEERFIELD, Ill.--(BUSINESS WIRE)---- $WBA #earnings--Walgreens Boots Alliance, Inc. today announced financial results for the third quarter of fiscal 2021, which ended May 31, 2021.

Walgreens Boots Alliance Fiscal 2021 Third Quarter Results Exceed Expectations

DEERFIELD, Ill.--(BUSINESS WIRE)--To honor the service and sacrifices of Americans who served in the armed forces, Walgreens is offering a weekend Independence Day discount to all veterans, active duty military personnel and their immediate family members, including the families of those who lost their lives in service to their country. Beginning July 1 through July 4, customers with a myWalgreens membership and valid military ID or proof of service will receive 20 percent off regularly priced

Walgreens Honors Veterans, Active Duty Military and Families with Weekend Discount in Honor of Independence Day

On Thursday, July 01, Walgreens Boots Alliance (NASDAQ:WBA) will release its latest earnings report. Decipher the announcement with Benzinga's help.

Earnings Preview: Walgreens Boots Alliance

AbbVie

AmerisourceBergen

Cardinal Health

CVS Health

Endo International

Johnson & Johnson

McKesson

Rite Aid

Teva Pharmaceutical

Walmart

Teva Pharmaceutical Industries Ltd (NYSE: TEVA), Endo International Plc (NASDAQ: ENDP), and AbbVie Inc's (NYSE: ABBV) Allergan misleadingly marketed opioid drugs as having a low addiction risk, a lawyer for a New York county told jurors, urging them to hold the companies liable. Jayne Conroy, representing Suffolk County, also said that the drug distributors - AmerisourceBergen Corp (NYSE: ABC), Cardinal Health Inc (NYSE: CAH), and McKesson Corp (NYSE: MCK) failed to report suspicious opioid orders as required.

New York Takes Drugmakers, Drug Retailers To Legal Trial Over Opioid

Micron Technology

Bed Bath & Beyond

General Mills

Constellation Brands

With the end of the second calendar quarter of 2021 colliding with the Independence Day holiday, the focus on earnings reports won't really begin until the week of July 12, when the country's largest banks will be revealing their results for the quarter.

Earnings Previews: Micron Technology, Walgreens and More

Walgreens Boots Alliance (WBA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Why Walgreens Boots Alliance (WBA) Might Surprise This Earnings Season

Alliance Pharma PLC (LON:APH) has appointed Kristof Neirynck as an independent non-executive director. He is currently group vice-president and chief marketing officer at retail pharmacy giant Walgreens-Boots-Alliance (WBA).

Alliance Pharma appoints top Walgreens-Boots-Alliance manager as non-executive director

Faster adoption of digital health and improved business environment are expected to have contributed to Walgreens' (WBA) third-quarter performance.

Walgreens (WBA) to Report Q3 Earnings: What's in Store?

Shaw Communications

A number of influential Canadian companies post earnings reports in the coming days. They're included in our seven to watch this week.

7 Stocks Reporting Earnings the Week of June 28

United Continental Hlds

ConocoPhillips

McCormick

Companies reporting or hosting investor days this week include Micron, United Airlines, Constellation Brands, Walgreens, and ConocoPhillips. Plus, jobs Friday.

United Airlines, Constellation Brands, Walgreens, Micron, and Other Stocks to Watch This Week

Merck

If you've been bitten by the shiba inu, try investing in the type of dog that pays.

Forget Dogecoin: These Dogs of the Dow Are More Likely to Make You Rich

The company is a Dividend Aristocrat, making it a great business to own for dividend investors. Its current valuation is very attractive and possibly undervalued.

Walgreens Boots Alliance: A Solid Company On Sale

DEERFIELD, Ill.--(BUSINESS WIRE)--Beginning today, customers getting a COVID-19 vaccination at Walgreens will receive $25 in Walgreens Cash rewards.* The Walgreens Cash rewards will be available immediately following the vaccination for those who have myWalgreens accounts. Individuals without a myWalgreens account can opt to receive a $25 Walgreens gift card following vaccination at Walgreens.† Parents or guardians of eligible adolescents ages 12-15 who get the vaccine will also be eligible to

News for Walgreens Stock (WBA)